Description

Arg-Gly-Glu-Ser TFA is a RGD-related peptide and a control for the RGDS ihibitory activity on fibrinogen binding to activated platelets.–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)—-C18H30F3N7O10—-[1]Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10:18.—-561.47–98.14–O=C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(O)=O)=O)=O)[C@H](CCCNC(N)=N)N.OC(C(F)(F)F)=O–Others–|H2O : 20 mg/mL (ultrasonic)–Others—-Others–Peptides